Kim MN - Search Results

1

Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients.

Argenziano ME, Kim MN, Montori M, Di Bucchianico A, Balducci D, Ahn SH, Svegliati Baroni G. Argenziano ME, et al. Among authors: kim mn. Hepatol Int. 2024 Oct;18(Suppl 2):922-940. doi: 10.1007/s12072-024-10692-4. Epub 2024 Jul 16. Hepatol Int. 2024. PMID: 39012579 Review.

2

[A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C].

Kim MN, Yoon KT, Park JY, Kim DY, Ahn SH, Chon CY, Han KH. Kim MN, et al. Among authors: kim dy. Korean J Hepatol. 2009 Dec;15(4):496-503. doi: 10.3350/kjhep.2009.15.4.496. Korean J Hepatol. 2009. PMID: 20037268 Korean.

3

Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir.

Kim MN, Kim SU, Park JY, Kim DY, Han KH, Chon CY, Ahn SH. Kim MN, et al. Among authors: kim su, kim dy. J Clin Gastroenterol. 2014 Mar;48(3):272-8. doi: 10.1097/MCG.0b013e31829a7247. J Clin Gastroenterol. 2014. PMID: 23811938

4

Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir.

Kim MN, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Han KH. Kim MN, et al. Among authors: kim su, kim dy, kim bk. Liver Int. 2014 Sep;34(8):1216-23. doi: 10.1111/liv.12377. Epub 2013 Nov 24. Liver Int. 2014. PMID: 24267737

5

Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy.

Kim MN, Lee CK, Ahn SH, Lee S, Kim SU, Kim DY, Kim HS, Han KH, Chon CY, Park JY. Kim MN, et al. Among authors: kim su, kim dy, kim hs. Liver Int. 2014 Nov;34(10):1543-9. doi: 10.1111/liv.12437. Epub 2014 Jan 12. Liver Int. 2014. PMID: 24330475 Clinical Trial.

6

Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis.

Kim MN, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Song KJ, Park YN, Han KH. Kim MN, et al. Among authors: kim su, kim dy, kim bk. Hepatology. 2015 Jun;61(6):1851-9. doi: 10.1002/hep.27735. Epub 2015 Mar 20. Hepatology. 2015. PMID: 25643638 Clinical Trial.

7

Prevention of hepatocellular carcinoma: beyond hepatitis B vaccination.

Kim MN, Han KH, Ahn SH. Kim MN, et al. Semin Oncol. 2015 Apr;42(2):316-28. doi: 10.1053/j.seminoncol.2014.12.018. Epub 2014 Dec 31. Semin Oncol. 2015. PMID: 25843736 Review.

8

Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adefovir combination therapy.

Kim MN, Park JY, Ahn SH, Kim BK, Kim SU, Kim DY, Han KH. Kim MN, et al. Among authors: kim su, kim dy, kim bk. J Med Virol. 2017 Jan;89(1):85-90. doi: 10.1002/jmv.24616. Epub 2016 Jul 11. J Med Virol. 2017. PMID: 27357598

9

Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C.

Kim MN, Kim HS, Kim JK, Kim BK, Kim SU, Park JY, Kim do Y, Ahn SH, Han KH. Kim MN, et al. Among authors: kim jk, kim su, kim bk, kim do y, kim hs. J Korean Med Sci. 2016 Sep;31(9):1431-7. doi: 10.3346/jkms.2016.31.9.1431. J Korean Med Sci. 2016. PMID: 27510387 Free PMC article.

10

Validation of PAGE-B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir.

Kim MN, Hwang SG, Rim KS, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim SU. Kim MN, et al. Among authors: kim su, kim dy, kim bk. Liver Int. 2017 Dec;37(12):1788-1795. doi: 10.1111/liv.13450. Epub 2017 May 12. Liver Int. 2017. PMID: 28418595

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

743 results

Search Page

Filters